Company Monitoring Page for Janssen

latest headlines for company on cafepharma

In a first, Janssen submits lung cancer bispecific hopeful amivantamab to the FDA
Fierce Biotech
Thu, 12/3/20 - 10:55 am
Tags:
Janssen, non-small cell lung cancer, FDA, amivantamab, JNJ, metastatic non-small cell lung cancer
Janssen buys up eye disorder gene therapy asset from Hemera Biosciences
Fierce Biotech
Wed, 12/2/20 - 10:45 am
Tags:
Janssen, JNJ, Hemera Biosciences, gene therapy, HMR59, geographic atrophy
Pfizer, Moderna apply for EMA authorization; Janssen's candidate begins rolling review
RAPS.org
Tue, 12/1/20 - 11:45 pm
Tags:
Pfizer, Moderna Therapeutics, Emergency Use Authorization, FDA, vaccines, JNJ, Janssen
Johnson & Johnson assures docs and patients its Janssen pharma unit 'Never Stops'
Fierce Pharma
Wed, 11/25/20 - 10:41 am
Tags:
JNJ, Janssen, DTC advertising, corporate branding
Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission
Pharmaforum
Fri, 11/13/20 - 12:11 pm
Tags:
Janssen, Multiple Myeloma, Darzalex, EMA, FDA
Johnson & Johnson readies to resume COVID-19 vaccine trial in the US
Biopharma Reporter
Mon, 10/26/20 - 11:03 am
Tags:
J&J, COVID-19, vaccines, Janssen
Janssen’s Simponi Aria Gains Extended FDA Approvals for Rare Children’s Arthritis Conditions
Xtalks
Tue, 10/6/20 - 11:19 pm
Tags:
Janssen, JNJ, Simponi Aria, polyarticular juvenile idiopathic arthritis, FDA
Michigan’s GRAM Inks COVID-19 Vaccine Manufacturing Deal with J&J
BioSpace
Tue, 09/29/20 - 11:59 am
Tags:
GRAM, Janssen, JNJ, drug manufacturing, vaccines, COVID-19, CDMOs
Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties
BioSpace
Wed, 09/23/20 - 10:22 am
Tags:
Genmab, JNJ, Janssen, Darzalex, arbitration, Multiple Myeloma
Janssen files Darzalex Faspro for rare disease light chain amyloidosis
Pharmaforum
Sat, 09/12/20 - 10:16 pm
Tags:
JNJ, Janssen, Darzalex Faspro, light chain amyloidosis
Janssen gets expanded EC nod for blood cancer combo drug Imbruvica plus rituximab
Pharmaceutical Business Review
Tue, 09/8/20 - 10:41 am
Tags:
JNJ, Janssen, Europe, Imbruvica, rituximab, CLL
J&J to start mid-stage coronavirus vaccine trials in three European countries
Reuters
Fri, 08/28/20 - 10:55 am
Tags:
JNJ, Janssen, vaccines, COVID-19, clinical trials, Europe, Spain, The Netherlands, Germany
Five Top Drugmakers Reveal List vs. Net Price Gaps
Drug Channels
Tue, 08/11/20 - 01:17 pm
Tags:
Eli Lilly, Janssen, Merck, Novartis, Sanofi, drug pricing
Janssen’s Tremfya gets FDA approval for active psoriatic arthritis
Pharmaceutical Business Review
Wed, 07/15/20 - 10:20 am
Tags:
Janssen, JNJ, FDA, Tremfya, psoriatic arthritis
Rebooting the healthcare system post-COVID-19
Pharmaforum
Mon, 07/13/20 - 11:30 pm
Tags:
Janssen, Healthcare, pharma industry, pandemic, COVID-19, innovation, patients, technology
J&J’s Ebola vaccine approved in EU
Pharmaforum
Fri, 07/3/20 - 01:07 pm
Tags:
Europe, JNJ, ebola virus, Janssen, vaccines, Bavarian Nordic
J&J scraps late-stage study testing Stelara for lupus
Reuters
Sat, 06/27/20 - 11:40 pm
Tags:
JNJ, Janssen, lupus, Stelara, clinical trials
J&J brings forward start of COVID-19 vaccine trial to next month
Pharmaforum
Wed, 06/10/20 - 11:51 pm
Tags:
JNJ, vaccines, Janssen, COVID-19, Ad26.COV2-S
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
BioSpace
Mon, 05/18/20 - 10:37 am
Tags:
JNJ, Janssen, teclistamab, JNJ-7957, clinical trials, ASCO 2020, Multiple Myeloma
Janssen promotes R&D exec into newfound data science role
Fierce Biotech
Wed, 05/6/20 - 12:15 pm
Tags:
JNJ, Janssen, R&D, data science, Najat Khan

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.